0001209191-21-066102.txt : 20211122 0001209191-21-066102.hdr.sgml : 20211122 20211122163037 ACCESSION NUMBER: 0001209191-21-066102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211118 FILED AS OF DATE: 20211122 DATE AS OF CHANGE: 20211122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YEAMAN KEVIN J CENTRAL INDEX KEY: 0001200469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 211432922 MAIL ADDRESS: STREET 1: C/O DOLBY LABORATORIES, INC. STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-18 0 0001308547 Dolby Laboratories, Inc. DLB 0001200469 YEAMAN KEVIN J C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 1 1 0 0 President and CEO Class A Common Stock 2021-11-18 4 M 0 29457 42.98 A 62352 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2021-11-18 4 S 0 4017 87.7074 D 58335 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2021-11-18 4 S 0 5672 88.8223 D 52663 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2021-11-18 4 S 0 6283 89.788 D 46380 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2021-11-18 4 S 0 13485 90.8093 D 32985 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 106414 D Employee Stock Option (right to buy) 42.98 2021-11-18 4 M 0 29457 0.00 D 2024-12-15 Class A Common Stock 29457 247414 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 The shares were sold in multiple transactions at prices ranging from $87.24 to $88.22, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $88.34 to $89.15 inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $89.37 to $90.34, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $90.46 to $91.18, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Shares held following the reported transactions include 106,414 restricted stock units, which are subject to forfeiture until they vest. This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. **All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.** /s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman 2021-11-18